OTCMKTS:ACUR - Acura Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.2050 -0.01 (-4.65 %)
(As of 02/17/2019 04:00 PM ET)
Previous Close$0.2050
Today's Range$0.20 - $0.23
52-Week Range$0.0601 - $0.75
Volume1,480 shs
Average Volume10,900 shs
Market Capitalization$4.37 million
P/E RatioN/A
Dividend YieldN/A
Beta2.67
Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of technologies and products to address medication abuse and misuse. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide. The company was founded in 1935 and is based in Palatine, Illinois.

Receive ACUR News and Ratings via Email

Sign-up to receive the latest news and ratings for ACUR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolOTCMKTS:ACUR
Previous SymbolNASDAQ:ACUR
CUSIP00509L70
Phone847-705-7709

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.97 million

Profitability

Net Income$-5,680,000.00
Net Margins-1,327.32%

Miscellaneous

Employees14
Market Cap$4.37 million
OptionableNot Optionable

Acura Pharmaceuticals (OTCMKTS:ACUR) Frequently Asked Questions

What is Acura Pharmaceuticals' stock symbol?

Acura Pharmaceuticals trades on the OTCMKTS under the ticker symbol "ACUR."

How were Acura Pharmaceuticals' earnings last quarter?

Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR) released its quarterly earnings results on Tuesday, November, 27th. The specialty pharmaceutical company reported ($0.05) earnings per share (EPS) for the quarter. The specialty pharmaceutical company had revenue of $0.07 million for the quarter. View Acura Pharmaceuticals' Earnings History.

When is Acura Pharmaceuticals' next earnings date?

Acura Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Thursday, June 6th 2019. View Earnings Estimates for Acura Pharmaceuticals.

What price target have analysts set for ACUR?

0 Wall Street analysts have issued 12 month target prices for Acura Pharmaceuticals' shares. Their predictions range from $0.55 to $0.55. On average, they expect Acura Pharmaceuticals' share price to reach $0.55 in the next year. This suggests a possible upside of 168.3% from the stock's current price. View Analyst Price Targets for Acura Pharmaceuticals.

Has Acura Pharmaceuticals been receiving favorable news coverage?

Media headlines about ACUR stock have been trending somewhat positive on Sunday, according to InfoTrie Sentiment. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Acura Pharmaceuticals earned a media sentiment score of 1.4 on InfoTrie's scale. They also gave press coverage about the specialty pharmaceutical company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Who are some of Acura Pharmaceuticals' key competitors?

Who are Acura Pharmaceuticals' key executives?

Acura Pharmaceuticals' management team includes the folowing people:
  • Mr. Robert B. Jones, CEO, Pres & Director (Age 60)
  • Mr. Peter A. Clemens, Sr. VP, CFO & Sec. (Age 66)
  • Dr. Albert W. Brzeczko, VP of Technical Affairs (Age 62)
  • Mr. James F. Emigh, VP of Corp. Devel. (Age 63)
  • Mr. Robert A. Seiser Ph.D., VP, Treasurer & Corp. Controller (Age 55)

How do I buy shares of Acura Pharmaceuticals?

Shares of ACUR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Acura Pharmaceuticals' stock price today?

One share of ACUR stock can currently be purchased for approximately $0.2050.

How big of a company is Acura Pharmaceuticals?

Acura Pharmaceuticals has a market capitalization of $4.37 million and generates $2.97 million in revenue each year. Acura Pharmaceuticals employs 14 workers across the globe.

What is Acura Pharmaceuticals' official website?

The official website for Acura Pharmaceuticals is http://www.acurapharm.com.

How can I contact Acura Pharmaceuticals?

Acura Pharmaceuticals' mailing address is 616 N. NORTH COURT SUITE 120, PALATINE IL, 60067. The specialty pharmaceutical company can be reached via phone at 847-705-7709 or via email at [email protected]


MarketBeat Community Rating for Acura Pharmaceuticals (OTCMKTS ACUR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  167 (Vote Outperform)
Underperform Votes:  126 (Vote Underperform)
Total Votes:  293
MarketBeat's community ratings are surveys of what our community members think about Acura Pharmaceuticals and other stocks. Vote "Outperform" if you believe ACUR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ACUR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2019 by MarketBeat.com Staff

Featured Article: Convertible Shares

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel